title: Optimum management of non-muscle-invasive micropapillary variant urothelial carcinoma: possibility for missed chance of cure?
authors.affiliation: Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Williams
authors.affiliation: Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Ashish M
authors.initials: AM
authors.lastname: Kamat
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000283:Administration, Intravesical; D001500:BCG Vaccine; D002291:Carcinoma, Papillary / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D003131:Combined Modality Therapy; D015653:Cystectomy; D006801:Humans; D007167:Immunotherapy; D009364:Neoplasm Recurrence, Local; D017410:Practice Guidelines as Topic; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine